Kim Boaz, Mitrofanis John, Stone Jonathan, Johnstone Daniel M
Bosch Institute, University of Sydney, NSW 2006, Australia.
Discipline of Physiology, University of Sydney, NSW 2006, Australia.
IBRO Rep. 2018 Jan 31;4:14-17. doi: 10.1016/j.ibror.2018.01.001. eCollection 2018 Jun.
Current treatments for Parkinson's disease (PD) are primarily symptomatic, leaving a need for treatments that mitigate disease progression. One emerging neuroprotective strategy is remote tissue conditioning, in which mild stress in a peripheral tissue (e.g. a limb) induces protection of life-critical organs such as the brain. We evaluated the potential of two remote tissue conditioning interventions - mild ischemia and photobiomodulation - in protecting the brain against the parkinsonian neurotoxin MPTP. Further, we sought to determine whether combining these two interventions provided any added benefit. Male C57BL/6 mice (n = 10/group) were pre-conditioned with either ischemia of the leg (4 × 5 min cycles of ischemia/reperfusion), or irradiation of the dorsum with 670 nm light (50 mW/cm, 3 min), or both interventions, immediately prior to receiving two MPTP injections 24 hours apart (50 mg/kg total). Mice were sacrificed 6 days later and brains processed for tyrosine hydroxylase immunohistochemistry. Stereological counts of functional dopaminergic neurons in the substantia nigra pars compacta revealed that both remote ischemia and remote photobiomodulation rescued around half of the neurons that were compromised by MPTP (< 0.001). Combining the two interventions provided no added benefit, rescuing only 40% of vulnerable neurons (< 0.01). The present results suggest that remote tissue conditioning, whether ischemia of a limb or photobiomodulation of the torso, induces protection of brain centers critical in PD. The lack of additional benefit when combining these two interventions suggests they may share common mechanistic pathways. Further research is needed to identify these pathways and determine the conditioning doses that yield optimal neuroprotection.
帕金森病(PD)目前的治疗主要是对症治疗,因此仍需要能够减缓疾病进展的治疗方法。一种新兴的神经保护策略是远程组织预处理,即在外周组织(如肢体)施加轻度应激,从而诱导对大脑等生命关键器官的保护作用。我们评估了两种远程组织预处理干预措施——轻度缺血和光生物调节——对大脑抵御帕金森病神经毒素MPTP的保护潜力。此外,我们试图确定将这两种干预措施联合使用是否能带来额外益处。雄性C57BL/6小鼠(每组n = 10只)在接受间隔24小时的两次MPTP注射(总量50 mg/kg)之前,立即接受腿部缺血预处理(4个5分钟的缺血/再灌注循环)、背部670 nm光照预处理(50 mW/cm,3分钟)或两种干预措施联合预处理。6天后处死小鼠,对大脑进行酪氨酸羟化酶免疫组织化学检测。对黑质致密部功能性多巴胺能神经元进行体视学计数发现,远程缺血和远程光生物调节均挽救了约一半因MPTP受损的神经元(<0.001)。两种干预措施联合使用未带来额外益处,仅挽救了40%的易损神经元(<0.01)。目前的结果表明,远程组织预处理,无论是肢体缺血还是躯干光生物调节,均可诱导对PD中关键脑区的保护作用。这两种干预措施联合使用时未带来额外益处,提示它们可能共享共同的机制途径。需要进一步研究以确定这些途径,并确定产生最佳神经保护作用的预处理剂量。